Please assess the completion status of the following clinical trial:

Trial Title: Red Blood Cell Transfusion in Patients With Coronary Artery Disease (CAD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ACS as defined by a patient who has cardiac chest discomfort and a troponin (cTnT) elevation of greater than 0.1 ng/mL.~* Pt. who is s/p CABG~* Patients with chronic coronary artery disease will be recruited as defined as past history of myocardial infarction, percutaneous coronary intervention, CABG, or history of coronary artery disease documented in the medical record.~* Anemia as defined by HCT between 21%-30%.~Exclusion Criteria:~* Patients with stage III/IV heart failure~* Patients who are actively bleeding requiring immediate transfusion.~* Pregnant patients will be excluded.~* Patients taking sildenafil (Viagra) or other drugs like it, such as vardenafil (Levitra), or tadalafil (Cialis) within 48 hours before the study.~* Patients on iv nitroglycerine infusion.~* Patients who present with ACS or CABG surgery and who are hemodynamically unstable or require immediate revascularization.~* Patients who have received a blood transfusion 24 hours prior to the start of the study.~* Patients with a HCT of \< 21% and those that have chest tube drainage greater then 30 mL/h will be excluded.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- RBC transfusion (Type: ACTIVE_COMPARATOR): None
- Normal saline infusion (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).